0001831283-23-000094.txt : 20230623 0001831283-23-000094.hdr.sgml : 20230623 20230623162208 ACCESSION NUMBER: 0001831283-23-000094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230621 FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS CENTRAL INDEX KEY: 0001413822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40947 FILM NUMBER: 231037986 MAIL ADDRESS: STREET 1: 333 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LianBio CENTRAL INDEX KEY: 0001831283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 486-2308 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 wk-form4_1687551713.xml FORM 4 X0407 4 2023-06-21 0 0001831283 LianBio LIAN 0001413822 GIANAKAKOS ANASTASIOS C/O LIANBIO 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 1 0 0 0 0 Stock Option (Right to Buy) 2.40 2023-06-21 4 A 0 36300 0 A 2033-06-21 Ordinary Shares 36300 36300 D The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. By: /s/ Angela Chen, Attorney-in-Fact 2023-06-23